LIQUAEMIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Liquaemin Sodium, and what generic alternatives are available?
Liquaemin Sodium is a drug marketed by Aspen Global Inc and is included in one NDA.
The generic ingredient in LIQUAEMIN SODIUM is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Liquaemin Sodium
A generic version of LIQUAEMIN SODIUM was approved as heparin sodium by HOSPIRA on April 28th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIQUAEMIN SODIUM?
- What are the global sales for LIQUAEMIN SODIUM?
- What is Average Wholesale Price for LIQUAEMIN SODIUM?
Summary for LIQUAEMIN SODIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | LIQUAEMIN SODIUM at DailyMed |